Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

83.31USD
16 Feb 2018
Change (% chg)

$0.37 (+0.45%)
Prev Close
$82.94
Open
$82.80
Day's High
$83.76
Day's Low
$82.14
Volume
2,467,437
Avg. Vol
1,399,300
52-wk High
$89.71
52-wk Low
$76.52

Latest Key Developments (Source: Significant Developments)

Medtronic Receives FDA Clearance For Riptide Aspiration System
Tuesday, 16 Jan 2018 10:01am EST 

Jan 16 (Reuters) - Medtronic Plc ::MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM.MEDTRONIC SAYS UNIT RECEIVED U.S. FDA CLEARANCE OF RIPTIDE ASPIRATION SYSTEM.  Full Article

FDA Approves Innovative Clinician Programmer For The Medtronic Synchromed II Intrathecal Drug Delivery System
Wednesday, 10 Jan 2018 07:00am EST 

Jan 10 (Reuters) - Medtronic Plc ::FDA APPROVES INNOVATIVE CLINICIAN PROGRAMMER FOR THE MEDTRONIC SYNCHROMED II INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN AND SEVERE SPASTICITY.  Full Article

Medtronic reports Q2 non-GAAP earnings per share of $1.07
Tuesday, 21 Nov 2017 06:45am EST 

Nov 21 (Reuters) - Medtronic Plc :Medtronic reports second quarter financial results.Q2 non-GAAP earnings per share $1.07.Q2 GAAP earnings per share $1.48.Q2 earnings per share view $0.98 -- Thomson Reuters I/B/E/S.Medtronic Plc - ‍company reiterates full year revenue and EPS guidance​.Medtronic Plc - qtrly ‍revenue of $7.1 billion​.Q2 revenue view $6.93 billion -- Thomson Reuters I/B/E/S.Medtronic plc qtrly ‍CVG worldwide revenue of $2.773 billion increased 7 percent on both a reported and constant currency basis​.Medtronic plc qtrly ‍RTG worldwide revenue of $1.863 billion increased 2 percent on both a reported and constant currency basis​.FY2018 earnings per share view $4.68, revenue view $29.36 billion -- Thomson Reuters I/B/E/S.Medtronic Plc qtrly ‍spine revenue of $659 million decreased 1 percent on both a reported and constant currency basis​.Medtronic Plc - ‍in fiscal year 2018, company continues to expect comparable, constant currency revenue growth to be in range of 4 to 5 percent​.Medtronic Plc - "‍Hurricane Maria, in particular, significantly affected our manufacturing operations in Puerto Rico"​ for quarter.  Full Article

Medtronic announces FDA approval and U.S. launch of next generation pacemakers
Monday, 20 Nov 2017 09:00am EST 

Nov 20 (Reuters) - Medtronic Plc :Medtronic announces FDA approval and U.S. launch of next generation pacemakers.Medtronic Plc - announces ‍U.S. FDA approval and U.S. commercial launch of portfolio of Azure pacemakers with Bluesync technology​.  Full Article

Medtronic ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​
Wednesday, 8 Nov 2017 04:45pm EST 

Nov 8 (Reuters) - Medtronic Plc :Medtronic announces preliminary second quarter revenue.Medtronic PLC - ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​.Medtronic PLC - ‍preliminary Q2 revenue of approximately $7.1 billion​.Medtronic PLC - ‍company announced that impact of hurricane maria was approximately $55 to $65 million to its q2 revenue​.Medtronic - preliminary ‍Q2 revenue increased 3 percent on comparable, constant currency basis.Medtronic PLC - ‍impact of hurricane maria expected to be approximately $0.03 to its q2 non-gaap earnings per share​.Medtronic - ‍excluding impact of hurricane maria, prelim. Q2 revenue growth would have been 4 percent on comparable, constant currency basis​.Medtronic PLC - expects a one cent positive impact to Q2 adjusted EPS from foreign currency​.Q2 earnings per share view $0.94, revenue view $6.87 billion -- Thomson Reuters I/B/E/S.  Full Article

Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies
Monday, 9 Oct 2017 08:00am EDT 

Oct 9 (Reuters) - Medtronic Plc :Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies when used with Heli-FX EndoAnchor system.Medtronic - ‍expanded indication enables Endurant II/IIs stent graft to be used in conjunction with Heli-FX EndoAnchor system.  Full Article

J&J diabetes care company Animas to close operations and exit insulin pump market
Thursday, 5 Oct 2017 07:00am EDT 

Oct 5 (Reuters) - Johnson & Johnson : :‍Johnson & Johnson Diabetes Care Companies - Animas corp intends to discontinue manufacturing, sale of animas vibe and onetouch ping insulin pumps.‍Johnson & Johnson Diabetes Care Companies - Animas corp also intends to close operations and exit insulin pump business​.‍Johnson & Johnson Diabetes Care Companies - Animas selected Medtronic as partner to facilitate transition for patients, caregivers, healthcare providers​.‍Johnson & Johnson Diabetes Care Companies - patients using an Animas insulin pump will be offered option to transfer to a Medtronic pump​.‍Johnson & Johnson Diabetes Care Companies - Johnson & Johnson is continuing to evaluate potential strategic options for Lifescan Inc​.‍Johnson & Johnson Diabetes Care Companies - for patients, healthcare providers outside of U.S., Canada Animas to continue to sell pumps, operate as usual​.  Full Article

Medtronic receives U.S. FDA approval for its HeartWare HVAD System for destination therapy​
Wednesday, 27 Sep 2017 04:05pm EDT 

Sept 27 (Reuters) - Medtronic Plc :Medtronic HeartWare(TM) HVAD(TM) system approved for destination therapy.Medtronic Plc - ‍Has received U.S. Food and Drug Administration approval for its HeartWare HVAD System​.  Full Article

Medtronic announces FDA approval, U.S. launch of spinal cord stimulator
Monday, 18 Sep 2017 09:00am EDT 

Sept 18 (Reuters) - Medtronic Plc :Medtronic announces FDA approval and U.S. launch of next generation spinal cord stimulator for chronic pain management.  Full Article

New five-year gender subset data from the Medtronic engage registry presented in viva late breaking trials
Wednesday, 13 Sep 2017 01:49pm EDT 

Sept 13 (Reuters) - Medtronic Plc :New five-year gender subset data from the medtronic engage registry presented in viva late breaking trials.Says ‍endurant ii aaa stent graft system continues to demonstrate "long-term durability and consistent" outcomes in among both male, female patients​.  Full Article

Cardinal Health profit beats on CVS tie-up, Medtronic unit buy

Cardinal Health's quarterly profit topped analysts' estimates as the U.S. drug distributor benefited from its purchase of Medtronic Plc's patient care business and a tie-up with drugstore chain CVS Health Corp .